Skip to main content

Advertisement

SpringerLink
Log in

Usefulness of antithrombin III and α2-plasmin inhibitor in early differentiation of fulminant hepatitis and severe form of acute hepatitis

  • Original Article
  • Published:
Gastroenterologia Japonica Aims and scope Submit manuscript

Summary

To evaluate the usefulness of antithrombin III (AT III) and α2 -plasmin inhibitor (α2PI) in early differential diagnosis of fulminant hepatitis from the severe form of acute hepatitis, the activities of AT III and α2PI were measured in plasma of 15 patients with fulminant hepatitis and 6 patients with severe form of acute hepatitis. The activities of prothrombin time (PT), hepaplastintest (HPT) and thrombotest (TT) were also evaluated. The mean values and the standard errors (SE) for PT, HPT and TT were 21.1 ±2.6%, 14.0 ±1.6% and 10.3 ±1.7%, respectively, in the early stage of fulminant hepatitis and 25.3 ±2.4%, 21.6 ±4.6% and 15.8 ±3.6%, respectively, in the severe form of acute hepatitis. No significant difference in the tests between these two diseases was noted. On the other hand, the mean values ±SE for AT III and α2PI were 13.7 ±4.6% and 25.6 ±8.6% in fulminant hepatitis and 70.2 ±28.5% and 98.7 ±9.7% in the severe form of acute hepatitis. A significant difference between the two diseases was observed. From the above, it is concluded that measuring AT III and α2Pl along with PT, HPT and TT is useful for early diagnosis of fulminant hepatitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hillenbrand P, et al: Significance of intravascular coagulation and fibrinolysis in acute hepatic failure. Gut 15: 83, 1974

    Article  PubMed  CAS  Google Scholar 

  2. Owren PA: Blood coagulation in liver diseases. Blood & Vessel 8: 1, 1977

    Google Scholar 

  3. Yamashina A: Experimental and clinical studies on blood coagulation in liver diseases. Acta Hepatologica Jpn l7:425, 1976 (Jpn)

    Google Scholar 

  4. Quick AJ: Prothrombin in hemophilia and in obstructive jaundice. J Biol Chem 109: 73, 1935

    Google Scholar 

  5. Owren PA, et al: Normotest. Farmakoterapi 25: 14, 1969

    CAS  Google Scholar 

  6. Owren PA: Thrombotest. A new method for controlling anticoagulant therapy. Lancet 2: 754, 1959

    Article  PubMed  CAS  Google Scholar 

  7. Clauss A: Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haem 17: 237, 1957

    CAS  Google Scholar 

  8. Astrup T, et al: Fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys 40: 346, 1952

    Article  PubMed  CAS  Google Scholar 

  9. Fujimaki M, et al: Immunological determination of FDP. Clinical Immunology 6: 557, 1974 (Jpn)

    Google Scholar 

  10. Ødegord OR, et al: Heparin cofactor activity measured with an amidolytic method. Thrombo Res 6: 287, 1975

    Article  Google Scholar 

  11. Naito K, et al: Assay of α2plasmin inhibitor activity by means of a plasma specific tripeptide substrate. Thrombo Res 12: 1147, 1978

    Article  CAS  Google Scholar 

  12. Iwabuchi S, et al: Clinical significance of antithrombin III activity in liver disease. Blood & Vessel 12: 412, 1981 (Jpn)

    Google Scholar 

  13. Aoki N, et al: The α2plasmin inhibitor levels in liver diseases. Clini Chim Acta 84: 99, 1978

    Article  CAS  Google Scholar 

  14. Boyadjian H: Changes in antithrombin III activity in the various clinical forms of viral hepatitis. Folia Medica 23: 11, 1981

    PubMed  CAS  Google Scholar 

  15. Cucuianu MP, et al: Increased plasma antithrombin III level in hyperlipidemic subjects. Clin Chim Acta 110: 147, 1981

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The First Department of Internal Medicine, Iwate Medical University, 19-1 Uchimaru, 020, Morioka, Japan

    Shunichi Sato M.D., Akihiko Murakami M.D., Toshimi Yoshida M.D., Toshifumi Kashiwabara M.D., Kazuyuki Suzuki M.D. & Isamu Kaito M.D.

Authors
  1. Shunichi Sato M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akihiko Murakami M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toshimi Yoshida M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Toshifumi Kashiwabara M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kazuyuki Suzuki M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Isamu Kaito M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sato, S., Murakami, A., Yoshida, T. et al. Usefulness of antithrombin III and α2-plasmin inhibitor in early differentiation of fulminant hepatitis and severe form of acute hepatitis. Gastroenterol Jpn 18, 128–136 (1983). https://doi.org/10.1007/BF02774687

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02774687

Key words

Search

Navigation